Search Results 101-110 of 16881 for Amphotericin B

  1. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma · Share ...

  2. Kristen B. McCullough, Pharm.D., R.Ph. - Doctors and Medical Staff - Mayo Clinic

    Kristen McCullough, Pharm.D., is a hematology clinical pharmacy specialist with interest in acute leukemias, chronic myeloid leukemia, myeloproliferative ...

  3. Publications - Amanda B. Ebright, M.D. - Mayo Clinic

    Kasten MJ, Berman AC, Ebright AB, Mitchell JD, Quirindongo-Cedeno O. Interpreters in Health Care: A Concise Review for Clinicians. Am J Med.

  4. Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma - Mayo Clinic

    Clinical Trials · Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma · More about research at Mayo ...

  5. Hepatitis B Research Network Adult Cohort Study - Mayo Clinic

    The primary purpose of this study is to describe participants with hepatitis B virus (HBV) infection and identify factors that may cause the disease to activate ...

  6. Publications - Maheen Z. Abidi, M.B.B.S., M.D. - Mayo Clinic

    Hepatitis B transmission/reactivation associated with Hepatitis B ... Sartain E, Schoeppler K, Crowther B ... amphotericin combination therapies. Mycoses. 2014 ...

  7. Publications - Emrys Fonseca, M.B., B.Ch., B.A.O., M.S. - Mayo Clinic

    JJ Matthews, FD Fonseca, CV Varnado. Help-seeking behaviors of African Americans after a loss Journal of Multicultural Counseling and Development. 2021; 60-71.

  8. Amanda B. Ebright, M.D. - Doctors and Medical Staff - Mayo Clinic

    Excellence in Teaching RecognitionMayo Medical School, Mayo Clinic College of Medicine and Science, Department of Education Administration.

  9. A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3) - Mayo Clinic

    ... B-precursor acute lymphoblastic leukemia (ALL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

  10. James T. Paget, B.M., B.Ch., Ph.D.

    James Paget, B.M. B.Ch., Ph.D., is a U.S. fellowship-trained Plastic surgeon with expertise in reconstruction after cancer. He attended medical school in ...